Thiolated chitosans: Influence of various sulfhydryl ligands on permeation-enhancing and P-gp inhibitory properties

Drug Development and Industrial Pharmacy

Volumn 37, Issue 6, 2011, Pages 648-655

  Sakloetsakun, Duangkamon ^a,b   Iqbal, Javed ^a   Millotti, Gioconda ^a   Vetter, Anja ^a   Bernkop Schnürch, Andreas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Drug absorption; efflux pump inhibition; permeation enhancing effect; thiolated chitosans; thiomers

Indexed keywords

4 THIOBUTYLAMIDINE; 6 MERCAPTONICOTINIC ACID; ACETYLCYSTEINE; CHITOSAN; CYSTEINE; DEXTRAN; FLUORESCEIN ISOTHIOCYANATE; GLUTATHIONE; GLYCOPROTEIN P; PENETRATION ENHANCING AGENT; RHODAMINE 123; THIOGLYCOLIC ACID; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONJUGATION; DISULFIDE BOND; DRUG ABSORPTION; HYDROPHILICITY; INTESTINE MUCOSA; MALE; NONHUMAN; PERMEABILITY; RAT;

ANIMALS; CHITOSAN; DEXTRANS; DRUG CARRIERS; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; FREEZE DRYING; INTESTINAL ABSORPTION; INTESTINES; MALE; P-GLYCOPROTEIN; PERMEABILITY; RATS; RATS, WISTAR; RHODAMINE 123; SULFHYDRYL COMPOUNDS;

EID: 79955973012     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2010.534484     Document Type: Article

References (23)

1. Chandy T, Sharma C. (1990). Chitosan-as a biomaterial. Biomater Artif Cells Artif Organs, 18:1-24.
2. Hejazi R, Amiji M. (2003). Chitosan-based gastrointestinal delivery systems. J Control Release, 89:151-165. (Pubitemid 36507012)
3. Schipper N, Olsson S, Hoogstraate J, deBoer A, Varum K, Artursson P. (1997). Chitosans as absorption enhancers for poorly absorbable drugs 2: Mechanism of absorption enhancement. Pharm Res, 14:923-29. (Pubitemid 27326989)
4. Föger F, Hoyer H, Kafedjiiski K, Thaurer M, Bernkop-Schnürch A. (2006b). In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein. Biomaterials, 27:5855-60. (Pubitemid 44287029)
5. Föger F, Schmitz T, Bernkop-Schnürch A. (2006a). In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan. Biomaterials, 27:4250-55.
6. Föger F, Kafedjiiski K, Hoyer H, Loretzz B, Bernkop-Schnürch A. (2007). Enhanced transport of P-glycoprotein substrate saquinavir in presence of thiolated chitosan. J Drug Target, 15:132-39. (Pubitemid 46957699)
7. Werle M, Hoffer M. (2006). Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J Control Release, 111:41-46. (Pubitemid 43289993)
8. Kafedjiiski K, Föger F, Werle M, Bernkop-Schnürch A. (2005). Synthesis and in vitro evaluation of a novel chitosan-glutathione conjugate. Pharm Res, 22:1480-88. (Pubitemid 41215888)
9. Greindl M. (2008). Oral drug delivery: Design and in vitro/in vivo evaluation of novel permeation enhancers and efflux pump inhibitors. Innsbruck: University of Innsbruck.
10. Millotti G, Samberger C, Eleonore F, Sakloetsakun D, Bernkop- Schnürch A. (2010). Chitosan-4-mercaptobenzoic acid: Synthesis and characterization of a novel thiolated chitosan. J Mater Chem, 20:9-18.
11. Millotti G, Samberger C, Fröhlich E, Bernkop-Schnürch A. (2009). Chitosan-graft-6-mercaptonicotinic acid: Synthesis, characterization, and biocompatibility. Biomacromolecules, 10:3023-27.
12. Bernkop-Schnürch A, Schwarz V, Steininger S. (1999). Polymers with thiol groups: A new generation of mucoadhesive polymers? Pharm Res, 16:876-81. (Pubitemid 29284199)
13. Varma M, Ashokraj Y, Dey C, Panchagnula R. (2003). P-glycoprotein inhibitors and their screening: A perspective from bioavailability enhancement. Pharmacol Res, 48:347-59. (Pubitemid 36945333)
14. Clausen A, Kast C, Bernkop-Schnürch A. (2002). The role of glutathione in the permeation enhancing effect of thiolated polymers. Pharm Res, 19:602-8. (Pubitemid 34553666)
15. Bernkop-Schnürch A, Guggi D, Pinter Y. (2004b). Thiolated chitosans: Development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. J Control Release, 94:177-86. (Pubitemid 37542387)
16. Hombach J, Bernkop-Schnürch A. (2009). Chitosan solutions and particles: Evaluation of their permeation enhancing potential on MDCK cells used as blood brain barrier model. Int J Pharm, 376:104-9.
17. Moghaddam F, Atyabi F, Dinarvand R. (2009). Preparation and in vitro evaluation of mucoadhesion and permeation enhancement of thiolated chitosan-pHEMA core-shell nanoparticles. Nanomedicine, 5(2):14-20.
18. Bernkop-Schnürch A, Kast C, Guggi D. (2003). Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: Thiomer/GSH systems. J Control Release, 93:95-103. (Pubitemid 37421352)
19. Clausen A, Bernkop-Schnürch A. (2000). In vitro evaluation of the permeation-enhancing effect of thiolated polycarbophil. J Pharm Sci, 89:1253-61.
20. Collares-Buzato C, McEwan G, Jepson SN, Hirst B. (1994). Paracellular barrier and junctional protein distribution depend on basolateral extracellular Ca2+ in cultured epithelia. Biochim Biophys Acta, 1222:147-58.
21. Madsen F, Eberth K, Smart J. (1998). A rheological examination of the mucoadhesive/mucus interaction: The effect of mucoadhesive type and concentration. J Control Release, 50:167-78. (Pubitemid 28044111)
22. Szakacs G, Paterson J, Ludwig J, Booth-Genthe C, Gottesman M. (2006). Targeting multidrug resistance in cancer. Nat Rev Drug Discov, 5:219-34. (Pubitemid 43336035)
23. Bernkop-Schnürch A, Hornof M, Guggi D. (2004a). Thiolated chitosans. Eur J Pharm Biopharm, 57:9-17. (Pubitemid 38058800)